Browse by category

A large majority of older Americans feel that health insurance - including Medicare - should cover anti-obesity medications, according to...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Palatin Technologies has announced the FDA has granted "orphan drug" designation to PL7737, an oral treatment that activates the...

Researchers from the University of Cambridge have developed a smartphone app that uses machine learning to accurately determine body...

The United Laboratories International Holdings Limited’s (TUL) wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd....

Massachusetts Institute of Technology (MIT) researchers have revealed a drug delivery system that "paints" glucagon-like peptide-1...

The Obesity Action Coalition (OAC) and The Obesity Society (TOS) have sent a letter to the FDA, along with more than 20 leading...

Allurion Technologies has announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimise...

There are fundamental sex-based differences in how weight loss medications interact with human biology, according to a study by Olio...

Partial weight recurrence after substantial weight loss was associated with a less favourable cardiovascular risk profile and an...